Security Snapshot

AMGEN INC - COM Institutional Ownership

CUSIP: 031162100

13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

157

Shares (Excl. Options)

6,941,156

Price

$351.85

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COM
Price per share
$351.85
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
6,941,156
Total reported value
$2,276,513,372
Share change
0
Number of holders
157
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • 031162100 - AMGEN INC - COM is tracked under CUSIP 031162100.
  • 157 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 4 to 157 between Q4 2025 and Q1 2026.
  • Reported value moved from $28,002,427,384 to $2,276,513,372.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 157 institutions filings for Q1 2026.

Open SEC Evidence

Security key

031162100

Latest holder period

Q1 2026

13F holders

157

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 157 institutional investors reported holding 6,941,156 shares of AMGEN INC - COM.

Institutional Holders of AMGEN INC - COM across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 6,941,156 $2,276,513,372 $351.85 157
2025 Q4 85,553,229 $28,002,427,384 +$730,303,163 $327.31 4
2024 Q3 29,317,018 $9,446,236,370 +$111,335,477 $322.21 1
2024 Q2 75,014,210 $23,438,190,041 -$652,762,734 $312.45 2
2024 Q1 77,103,385 $21,922,034,518 -$49,180,252 $284.32 2
2023 Q4 77,276,360 $22,257,137,006 $288.02 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .